NVIDIA· AI platform

Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin

Erin Davis calls it the “SuperDuperPOD.” That’s two things in one name: pharmaceutical giant Bristol Myers Squibb (BMS) already runs one of the largest AI clusters in life sciences, with serious results to show for it. And they’re doubling down. BMS announced today it is deploying its second NVIDIA DGX SuperPOD , this one built on eight DGX Vera Rubin NVL72 systems — the most powerful and energy-efficient AI cluster in life sciences. “Instead of equipping a small group of researchers with access to the supercomputer, we’re opening it up to literally every scientist,” says Davis, vice president of research business insights and technology at BMS. “No one has to wait, and no one is told they have a limit.” The eight rack-scale systems, each comprising NVIDIA Vera CPUs and Rubin GPUs, deliver up to 10x the performance per megawatt of the infrastructure it replaces. It will give researchers at the global pharmaceutical giant access to a unified AI platform — including NVIDIA BioNeMo Agent Toolkit for biological AI — for running predictions, training models and powering agentic workflows across the full drug discovery pipeline. …

Announced

20 Jul 2026 10:59 UTC